tirzepatide surpass-5 Efficacy and safety of in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial SURPASS-5 Data: Tirzepatide Plus Insulin
Pay in 4 interest-free payments of $7.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10

01443-4/asset/1245bc8d-99c6-4ac1-b69b-8c0220ceb8fd/main.assets/gr1.jpg)

00243-1/asset/23df9500-d21e-4a61-9bfa-1536b8dc9f75/main.assets/gr4a_lrg.jpg)


























